Results

Total Results: 954 records

Showing results for "weight".
Users also searched for: obesity screening

881. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Evidence Summary Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions December 12, 2017 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Depart…

882. Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening
     September 06, 2016 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print Evidence Summary Latent Tuberculosis Infection: Screening September 06, 2016 Recommendations made by the USPSTF are independent of the U.S. gov…

883. Jepnfupw Kyd7Nhaf-To62
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JEpnfupw_kyd7Nhaf-to62
     October 11, 2022 - Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force Screening for Anxiety in Children and Adolescents Evidence Report and Systematic Review for the US Preventive Services Task Force Meera Viswanathan, PhD; Ina F. Wallace, PhD; Jennifer Coo…

884. Evidence Summary: Primary Open-Angle Glaucoma: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/primary-open-angle-glaucoma-screening
     May 24, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Primary Open-Angle Glaucoma: Screening May 24, 2022 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed…

885. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication
     May 15, 2009 - to Table of Contents Discussion New evidence from observational studies provides weight … Lowered weight gain during pregnancy and risk of neural tube defects among offspring. … terminated from 1989 to 1991 in most California counties to examine the potential relationship between weight … of infants without any major anomalies Exposure: periconceptional or pregnancy use of folic acid and weight

886. Ykjvkfmv5Jf8Bl3Rbx8Bp7 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
     December 01, 2015 - insufficient to conclude that pharmacologic interventions have the same multifactorial benefits (for example, weight … Effective programs commonly in- clude setting a weight loss goal, individual or group sessions about … Lifestyle modification and prevention of type 2 diabetes in over- weight Japanese with impaired fasting … Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention

887. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
     May 15, 2009 - New evidence from observational studies provides weight … Lowered weight gain during pregnancy and risk of neural tube defects among offspring. … terminated from 1989 to 1991 in most California counties to examine the potential relationship between weight … of infants without any major anomalies Exposure: periconceptional or pregnancy use of folic acid and weight

888. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/y6xRBv7uSZY5bGCx7y48x7
     May 01, 2009 - DISCUSSION New evidence from observational studies provides weight to previous evidence from controlled … Lowered weight gain during pregnancy and risk of neural tube defects among offspring. … terminated from 1989 to 1991 in most California counties to examine the potential relationship between weight … of infants without any major anomalies Exposure: periconceptional or pregnancy use of folic acid and weight

889. Screening for Depression in Adults: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/56vB_8UTTE_HjygLvJfYqM
     May 01, 2002 - estimates suggest that screening Screening for Depression in Adults 138 Screening Usual care RR Weight … 100.0 0.87[0.79,0.95] Test for heterogeneity chi-square=12.47 df=6 P=0.052 Screening Usual care RD Weight … Screening for Depression in Adults 140 Screening Usual care RR Weight RR Study n/N n/N (95% CI Random … 100.0 0.90[0.82,0.98] Test for heterogeneity chi-square=7.94 df=5 P=0.16 Screening Usual care RD Weight

890. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
     January 01, 2002 - differentiate Aspirin for the Primary Prevention of Cardiovascular Events 11 Aspirin Control OR Weight … Aspirin Control OR Weight OR Trial n/N n/N (95% CI Random) % (95% CI Random) BMD5 89/3,429 47/1,710 … Aspirin Control OR Weight OR Trial n/N n/N (95% CI Random) % (95% CI Random) BMD5 91/3,429 39/1,710 … Cardiovascular Events 13 Aspirin for the Primary Prevention of Cardiovascular Events 14 Aspirin Control OR Weight

891. Screening for Chlamydial Infection: An Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/REES__d2DxtDLhZCXQjpPW
     July 01, 2007 - pregnancy outcomes, including miscarriage, pre- mature rupture of membranes, preterm labor, low birth weight … of membranes, preterm labor, pre- term delivery, spontaneous abortion, endometritis, and low birth weight … This factor gives additional weight to the study findings.

892. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
     October 01, 2016 - Weight Loss/ 21. … Weight Loss/ 21. … Weight Loss/ Continued www.annals.org Annals of Internal Medicine • Vol. 165 No. 8 • 18 October 2016

893. Archived: Final Evidence Summary: Breastfeeding: Counseling, July 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/breastfeeding-counseling-2003
     July 01, 2003 - Maternal benefits of breastfeeding can include more rapid return of postpartum uterine tone and postpartum weight … One RCT of support in very low-birth-weight infants was excluded from the meta-analysis. 16 Mean differences … Randomized trial of breastfeeding support in very low-birth-weight infants.

894. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/crPsNJ_R5SFnJhuT2CEpkr
     March 01, 2019 - Risk of All-Cause Mortality and Selected Health Outcomes for Warfarin Compared With Controls (KQ4) Weight … 0.38 (0.25-0.59) Weights are from random-effects meta-analysis; size of data markers indicates the weight … Major Extracranial Bleeding, and Intracranial Hemorrhage for Warfarin Compared With Controls (KQ5) Weight … 0.01 101.0 1000.1 Weights are from random-effects meta-analysis; size of data markers indicates the weight

895. Archived: Gonorrhea (Including Ocular Prophylaxis in Newborns): Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gonorrhea-screening-1996
     January 01, 1996 - gonococcal infections are at increased risk for obstetric complications (e.g., stillbirth, low birth weight … Maternal gonococcal infection as a preventable risk factor for low birth weight.

896. Archived: Gonorrhea (Including Ocular Prophylaxis in Newborns): Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gonorrhea-screening-including-ocular-prophylaxis-newborns-1996
     January 01, 1996 - gonococcal infections are at increased risk for obstetric complications (e.g., stillbirth, low birth weight … Maternal gonococcal infection as a preventable risk factor for low birth weight.

897. Archived: Tobacco Use Prevention: Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-prevention-counseling-1996
     January 01, 1996 - Smoking during pregnancy causes about 5-6% of perinatal deaths, 17-26% of low-birth-weight births, and … controlled trials, smoking cessation counseling with self-help materials significantly increased mean birth weight … Sexton M, Hebel JR A clinical trial of change in maternal smoking and its effect on birth weight.

898. Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     April 08, 2014 - Daily aspirin doses ranged from 60 to 150 mg, with 1 trial reporting a dose of 0.5 mg/kg of body weight … months and no treatment group differences in hospital visits, gross motor development, or height and weight … Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised … Birth weight in relation to morbidity and mortality among newborn infants. … Doppler ultrasonography and risk for PE or IUGR as determined by medical history 0.5 per kg of body weight

899. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     April 08, 2014 - Daily aspirin doses ranged from 60 to 150 mg, with 1 trial reporting a dose of 0.5 mg/kg of body weight … months and no treatment group differences in hospital visits, gross motor development, or height and weight … Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised … Birth weight in relation to morbidity and mortality among newborn infants. … Doppler ultrasonography and risk for PE or IUGR as determined by medical history 0.5 per kg of body weight

900. Archived: Final Evidence Review: Healthy Diet: Behavioral Counseling in Primary Care, January 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review41/diet-behavioral-counseling-primary-care-adults-2003
     January 15, 2003 - Studies that enrolled only overweight or obese patients for the purpose of weight management were not … reported only biochemical markers (e.g., serum vitamin A level) or anthropomorphic measures (e.g., weight … risk factors for heart disease Cont: usual health care advice from MD to reduce dietary fat, reduce weight … health care advice sessions Cont: usual health care advice from MD to reduce dietary fat, reduce weight … physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight